BST-1002

N/A

Report date: 2023/02/18 10:44:39

Base Information

Drug NameBST-1002

Drug Alias NameN/A

ClassificationOther

Mechanisms of ActionUndefined mechanism

TargetsNot applicable

Therapy Area/IndicationsNeoplasm Metastasis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBiostratum Ab

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBiostratum Ab

Active IndicationsN/A

Inactive IndicationsNeoplasm Metastasis

Other Information

ATC CodeN/A

Related LinksN/A